The estimated Net Worth of Pra Investors L.P.Kkr Pra I... is at least $3.32 milliard dollars as of 9 August 2018. Pra I owns over 6,500,000 units of PRA Health Sciences Inc stock worth over $1,106,243,517 and over the last 9 years Pra sold PRAH stock worth over $2,217,269,213.
Pra has made over 5 trades of the PRA Health Sciences Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Pra sold 6,500,000 units of PRAH stock worth $656,565,000 on 9 August 2018.
The largest trade Pra's ever made was selling 9,500,000 units of PRA Health Sciences Inc stock on 14 August 2017 worth over $711,075,000. On average, Pra trades about 6,647,535 units every 177 days since 2016. As of 9 August 2018 Pra still owns at least 6,695,984 units of PRA Health Sciences Inc stock.
You can see the complete history of Pra I stock trades at the bottom of the page.
Over the last 10 years, insiders at PRA Health Sciences Inc have traded over $5,843,308,181 worth of PRA Health Sciences Inc stock. The most active insiders traders include Fund Holdings L.P.Kkr Fund ..., Fund Holdings L.P.Kkr Fund ... et Pra Investors L.P.Kkr Pra I.... On average, PRA Health Sciences Inc executives and independent directors trade stock every 39 days with the average trade being worth of $280,602,577. The most recent stock trade was executed by Christopher L Gaenzle on 17 June 2021, trading 27,497 units of PRAH stock currently worth $2,773,897.
PRA is one of the world's leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA's global clinical development platform includes more than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and more than 18,100 employees worldwide. Since 2000, PRA has participated in approximately 4,200 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 100 drugs.
PRA Health Sciences Inc executives and other stock owners filed with the SEC include: